Literature DB >> 9313670

Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst.

L Daehlin1, B Tønder, L Kapstad.   

Abstract

OBJECTIVE: To compare the effects and side-effects of polidocanol and tetracycline when used as sclerosants for testicular hydrocele and epididymal cyst. PATIENTS AND METHODS: Forty-five men (median age 67 years, range 42-81) with 46 hydroceles or epididymal cysts were assessed. After puncture and aspiration, the empty sac was instilled with either polidocanol or tetracycline, assigned randomly. Patients recorded any treatment-associated pain on a visual analogue scale.
RESULTS: At 9 months of follow-up, nine of 17 men were cured after sclerotherapy with polidocanol compared with 17 of 20 men treated with tetracycline (P < 0.05). Tetracycline produced some pain for 3 days after treatment while polidocanol therapy was almost pain-free. Re-instillation should be considered for recurrences. At the follow-up after 35 months, 16 of 18 men treated with polidocanol and 20 of 22 men treated with tetracycline were satisfied with the outcome.
CONCLUSION: Both polidocanol and tetracycline are useful sclerosants for treating testicular hydrocele and epididymal cyst. We prefer polidocanol as a first choice in older patients because there were few short-term side-effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313670     DOI: 10.1046/j.1464-410x.1997.00358.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  The use of TPA in combination with alcohol in the treatment of the recurrent complex hydrocele.

Authors:  Michael J Metcalfe; Rebecca J Spouge; David J Spouge; Chris C Hoag
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Evaluation of the Role of Sodium Tetradecyl Sulfate as a Sclerosant in the Treatment of Primary Hydrocele.

Authors:  Osman Musa; Arijit Roy; Nisar Ahmad Ansari; Jagadamba Sharan
Journal:  Indian J Surg       Date:  2013-02-09       Impact factor: 0.656

3.  Sclerotherapy for hydrocele revisited: a prospective randomised study.

Authors:  M S Agrawal; H Yadav; A Upadhyay; R Jaiman; J Singhal; A K Singh
Journal:  Indian J Surg       Date:  2009-03-13       Impact factor: 0.656

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.